News Releases

Clean technology transportation pioneer, Martin Schuermann, appointed as Executive Chairman of Aberdeen’s Board of Directors Mr. Schuermann to drive refined focus on downstream, transportation and consumer-facing low-carbon strategy With addition of Mr. Schuermann, the Company elevates its governance, deal sourcing and execution capabilities TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Aberdeen International Inc. (“Aberdeen” or the “Company”) (TSX: AAB) (F: A8H) (OTC: AABVF) is pleased to announce the appointment of Martin Schuermann as Executive Chairman of the Board of Directors of the Company. Mr. Schuermann has been involved in the clean energy sector since 2009, serving as Chief Executive Officer […]

PowerTap Hydrogen Capital Corp. (PowerTap) acquisition implies ~200% return on Aberdeen’s investment in AES-100 Inc. over an approximate five month period Aberdeen gains strategic partner to accelerate commercialization of the Advanced Electrolyzer System (AES) in global transportation applications PowerTap brings significant technical and financial resources to support commercialization of the AES technology TORONTO, July 28, 2021 (GLOBE NEWSWIRE) — Aberdeen International Inc. (“Aberdeen” or the “Company”) (TSX: AAB F: A8H, OTC: AABVF) is pleased to inform that PowerTap Hydrogen Capital Corp. (NEO: MOVE) (FWB:2K6B) (OTC: MOTNF) (“PowerTap”) has acquired a 49% ownership stake in Aberdeen investee, AES-100 Inc. AES is […]

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) — ABERDEEN INTERNATIONAL INC. (“Aberdeen” or the “Company”) (TSX: AAB) has acquired 24,101,803 units of Medivolve Inc. (“Medivolve”) (NEO: MEDV) in a non-brokered private placement financing of MEDV at a price of $0.07 per unit for a total subscription price of $1,687,126.21. Each unit is comprised of one Medivolve common share and one Medivolve common share purchase warrant. Each common share purchase warrant is exercisable for one common share of Medivolve at a price of $0.08 for a period of five years. Prior to this transaction, Aberdeen did not own Common Shares of MEDIVOLVE. Subsequent to […]

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) — Aberdeen International Inc. (“Aberdeen” or the “Company”) (TSX: AAB) (FRANKFURT: A8H) (OTC: AABVF) reports, in accordance with the policies of the Toronto Stock Exchange, that the nominees listed in the management proxy circular dated June 14, 2021 for the 2021 annual meeting of shareholders of Aberdeen held on July 15, 2021 (the “Meeting”) were elected as directors of the Company. Aberdeen management would like to thank shareholders for their participation and continuing support. Detailed results of the vote for the election of directors held at the Meeting are set out below. A total of 33,876,003 […]

— Total revenue of $4.0 million, including net gain on investments of $3.9 million — Net income for the three months ended April 30, 2021 was $3.3 million or $0.02 per basic share — As at April 30, 2021, Aberdeen’s shareholders’ equity and net asset value (NAV) were $41.0 million, or $0.30 per share. On a quarter-over-year basis, Aberdeen’s shareholders’ equity has increased by $8.6 million, representing an approximate 26% increase. Given the nature of Aberdeen’s operations, there is currently no difference between “shareholder equity” and “net asset value” for Aberdeen — Investments in clean energy and zero-carbon technologies positioning […]